Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine

Bivalent rLP2086 (Trumenba), a vaccine for prevention of Neisseria meningitidis serogroup B (NmB) disease, was licensed for use in adolescents and young adults after it was demonstrated that it elicits antibodies that initiate complement-mediated killing of invasive NmB isolates in a serum bacterici...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:mBio
Main Authors: McNeil, Lisa K., Donald, Robert G. K., Gribenko, Alexey, French, Roger, Lambert, Nathaniel, Harris, Shannon L., Jones, Thomas R., Li, Sheng, Zlotnick, Gary, Vogel, Ulrich, Claus, Heike, Abad, Raquel, Vazquez, Julio A., Borrow, Ray, Findlow, Jamie, Taha, Muhamed-Kheir, Deghmane, Ala-Eddine, Caugant, Dominique A., Kriz, Paula, Musilek, Martin, Wang, Xin, Vuong, Jeni, Mayer, Leonard W., Pride, Michael W., Jansen, Kathrin U., Anderson, Annaliesa S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850321/
https://ncbi.nlm.nih.gov/pubmed/29535195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mBio.00036-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados